Oculis Holding AGOCSNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank75
3Y CAGR+216.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+216.0%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
31.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 78.08% |
| 2023 | 31.60% |
| 2022 | 132.27% |
| 2021 | 2.47% |
| 2020 | 0.00% |